Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7RM9

Human Malate Dehydrogenase I (MDHI)

Summary for 7RM9
Entry DOI10.2210/pdb7rm9/pdb
DescriptorMalate dehydrogenase, cytoplasmic, MALONATE ION (3 entities in total)
Functional Keywordsoxidoreductase
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight73044.17
Authors
McCue, W.,Finzel, B.C. (deposition date: 2021-07-27, release date: 2022-01-05, Last modification date: 2023-10-18)
Primary citationMcCue, W.M.,Finzel, B.C.
Structural Characterization of the Human Cytosolic Malate Dehydrogenase I.
Acs Omega, 7:207-214, 2022
Cited by
PubMed Abstract: The first crystal structure of the human cytosolic malate dehydrogenase I (MDH1) is described. Structure determination at a high resolution (1.65 Å) followed production, isolation, and purification of human MDH1 using a bacterial expression system. The structure is a binary complex of MDH1 with only a bound malonate molecule in the substrate binding site. Comparisons of this structure with malate dehydrogenase enzymes from other species confirm that the human enzyme adopts similar secondary, tertiary, and quaternary structures and that the enzyme retains a similar conformation even when nicotinamide adenine dinucleotide (NAD) is not bound. A comparison to the highly homologous porcine () MDH1 ternary structures leads to the conclusion that only small conformational differences are needed to accommodate binding by NAD or other NAD mimetics. Conformational differences observed in the second subunit show that the NAD binding elements are nevertheless quite flexible. Comparison of MDH1 to the human mitochondrial malate dehydrogenase (MDH2) reveals some key differences in the α7-α8 loop, which lies directly beneath the substrate binding pocket. These differences might be exploited in the structure-assisted design of selective small molecule inhibitors of MDH1, an emerging target for the development of anticancer therapeutics.
PubMed: 35036692
DOI: 10.1021/acsomega.1c04385
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.65 Å)
Structure validation

238895

数据于2025-07-16公开中

PDB statisticsPDBj update infoContact PDBjnumon